CN101843792A - Chinese medicament for treating angina - Google Patents

Chinese medicament for treating angina Download PDF

Info

Publication number
CN101843792A
CN101843792A CN200910238309A CN200910238309A CN101843792A CN 101843792 A CN101843792 A CN 101843792A CN 200910238309 A CN200910238309 A CN 200910238309A CN 200910238309 A CN200910238309 A CN 200910238309A CN 101843792 A CN101843792 A CN 101843792A
Authority
CN
China
Prior art keywords
chinese medicine
chinese
chinese medicament
fine powder
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910238309A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN200910238309A priority Critical patent/CN101843792A/en
Publication of CN101843792A publication Critical patent/CN101843792A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating angina, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: drug sweetflag rhizome, lucid ganoderma, radix rehmanniae praeparata, radix pseudo-ginseng, and Chinese angelica. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, and activating blood, dissolving stasis and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗心绞痛的中药 Chinese medicine for treating angina pectoris

技术领域technical field

本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.

背景技术Background technique

现在的旨在治疗心绞痛的中药领域,存在着一些问题:一是效果不够明显,二是见效比较迟缓。以致于许多心绞痛患者长期受到胸闷胸痛的折磨,发生心肌梗死的几率增大,影响了生存质量。There are some problems in the field of traditional Chinese medicine aimed at treating angina pectoris: the first is that the effect is not obvious enough, and the second is that the effect is relatively slow. As a result, many patients with angina pectoris suffer from chest tightness and pain for a long time, and the probability of myocardial infarction increases, which affects the quality of life.

针对以上提出的问题,本发明提供一种治疗心绞痛的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for treating angina pectoris, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and the effect is relatively slow. The advantages.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗心绞痛的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of angina pectoris, adopts Chinese medicine raw material to prepare, and formula is (by weight):

菖蒲3-20份    灵芝2-12份    熟地黄4-30份Calamus 3-20 parts Ganoderma lucidum 2-12 parts Rehmannia glutinosa 4-30 parts

三七3-20份    当归4-30份Panax notoginseng 3-20 parts Angelica 4-30 parts

这种治疗心绞痛的中药是由下列方法制成的:This traditional Chinese medicine for treating angina pectoris is made by the following method:

(1)按上述重量比,将菖蒲、熟地黄、当归经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, calamus, rehmannia glutinosa, and angelica are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝、熟地黄扶正培本,益气养血,养心安神,增强机体免疫力;当归、三七养血活血,化瘀止痛,扩张冠脉,增加冠脉血流量;辅以菖蒲芳香开窍,逐瘀祛浊,有镇静和镇痛作用。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀止痛之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. Ganoderma lucidum and Rehmannia glutinosa Fuzheng Peiben in the prescription can nourish qi and blood, nourish the heart and calm the nerves, and enhance the body's immunity; angelica and panax notoginseng nourish blood and activate blood, remove blood stasis and relieve pain, expand coronary arteries, and increase coronary blood flow; supplemented by calamus aroma To resuscitate, expel blood stasis and remove turbidity, has sedative and analgesic effects. All the medicines are compatible and complement each other, and play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation, removing blood stasis and relieving pain. The effect is good, and the effect is fast.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

菖蒲60克    灵芝40克    熟地黄80克Calamus 60 grams Ganoderma lucidum 40 grams Rehmannia glutinosa 80 grams

三七60克    当归80克Panax notoginseng 60 grams Angelica 80 grams

按规定重量,用常规水提取工艺将菖蒲、熟地黄、当归提取,制成浸膏细粉60克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊642粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract calamus, rehmannia glutinosa, and angelica to make 60 grams of extract powder, grind Ganoderma lucidum and Sanqi into fine powder, mix with the above extract powder, stir evenly, and prepare into fine granules, put into No. 0 capsules, and make 642 Chinese medicine capsules, each capsule containing Chinese medicine fine powder and 0.28 grams of extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

菖蒲120克    灵芝60克    熟地黄200克Calamus 120g Ganoderma lucidum 60g Rehmannia glutinosa 200g

三七120克    当归200克Panax notoginseng 120g Angelica 200g

按上述同样的方法,制成中药胶囊1400粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, make 1400 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

菖蒲200克    灵芝120克    熟地黄300克Calamus 200g Ganoderma lucidum 120g Rehmannia glutinosa 300g

三七200克    当归300克Sanqi 200g Angelica 300g

按上述同样的方法,制成中药胶囊2250粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, make 2250 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

菖蒲5份    灵芝3份    熟地黄7份5 parts of calamus, 3 parts of Ganoderma lucidum, 7 parts of Rehmannia glutinosa

三七5份    当归7份Panax notoginseng 5 parts Angelica 7 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

菖蒲10份    灵芝6份    熟地黄15份10 parts of calamus, 6 parts of Ganoderma lucidum, 15 parts of Rehmannia glutinosa

三七10份    当归15份Panax notoginseng 10 parts Angelica 15 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医心绞痛为例,经7例临床观察。选择中医诊断心绞痛为标准:胸闷胸痛,心慌心悸,四肢乏力,发作时心电图可见T波异常。如上症状,即可确诊。在确诊观察的对象中,男性4例,女性3例,无其它严重疾病,年龄为51岁-82岁,平均年龄66.4岁。The present invention takes angina pectoris of traditional Chinese medicine as an example, through clinical observation of 7 cases. Choose TCM diagnosis of angina pectoris as the standard: chest tightness and chest pain, palpitation and palpitation, limb weakness, abnormal T wave can be seen in the electrocardiogram during the attack. The above symptoms can be diagnosed. Among the objects under confirmed observation, there were 4 males and 3 females, without other serious diseases, aged 51-82 years, with an average age of 66.4 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,心区舒适,胸闷绞痛明显缓解或消失,心电图检查无异常。1. Significant effect: Physical fitness is enhanced, the heart area is comfortable, chest tightness and cramps are obviously relieved or disappeared, and the electrocardiogram is normal.

2、有效:体质有所增强,胸闷绞痛有所缓解。2. Effective: Physical fitness has been enhanced, and chest tightness and cramps have been relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的7人中,显效3人,有效3人,无效1人,总有效率85.7%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 7 people in the clinical trial, 3 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 85.7%.

Claims (1)

1. the anginal Chinese medicine of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Acori Graminei 3-20 part Ganoderma 2-12 part Radix Rehmanniae Preparata 4-30 part
Radix Notoginseng 3-20 part Radix Angelicae Sinensis 4-30 part
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Acori Graminei, Radix Rehmanniae Preparata, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
CN200910238309A 2009-11-18 2009-11-18 Chinese medicament for treating angina Pending CN101843792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910238309A CN101843792A (en) 2009-11-18 2009-11-18 Chinese medicament for treating angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910238309A CN101843792A (en) 2009-11-18 2009-11-18 Chinese medicament for treating angina

Publications (1)

Publication Number Publication Date
CN101843792A true CN101843792A (en) 2010-09-29

Family

ID=42768730

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910238309A Pending CN101843792A (en) 2009-11-18 2009-11-18 Chinese medicament for treating angina

Country Status (1)

Country Link
CN (1) CN101843792A (en)

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843661B (en) Chinese medicament for treating angina
CN101843690B (en) Chinese medicament for treating osteoporosis
CN102048899A (en) Traditional Chinese medicine preparation for treating impotence
CN101843712B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843753B (en) Chinese medicament for treating angina
CN101843738A (en) Chinese medicament for treating diabetic feet
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843720B (en) Chinese medicament for treating angina
CN101843708B (en) Chinese medicament for treating cervical spondylosis
CN101843644B (en) Chinese medicament for treating tachycardia
CN101843715A (en) Chinese medicament for treating diabetic feet
CN101843709A (en) Chinese medicament for treating abnormal menstruation
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843645B (en) Chinese medicament for treating tachycardia
CN101843793B (en) Chinese medicament for treating tachycardia
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843798B (en) Oral Chinese medicament for treating fracture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100929